Integra Stock Dips on Lowered Guidance After Q3 Sales Miss
Integra LifeSciences (Nasdaq: IART) shares fell after third-quarter results missed consensus forecasts.
Shares of IART dropped over 8% to $14.15 after the market opened. The company reported a loss of $5.4 million, or 7¢ per share, on sales of $402.1 million for the quarter ended September.
Integra recorded a 50% bottom-line gain on a 5.6% sales increase. Adjusted earnings per share were 54¢, exceeding Wall Street expectations by 11¢.
Sales, however, were lower than forecasted $414.3 million, due to "supply interruptions". The Codman Specialty Surgical business generated around 70% of revenue, at $292 million.
No comment from the company on the sales miss.
Author's summary: Integra LifeSciences' stock dips due to Q3 sales miss.
More News
- CNN announces election night coverage plans, including All Access-only ‘livecast’
- St. Louis’ Gray Design Group adds senior project manager – REJournals
- NBA head coach Tyronn Lue allegedly attended Chauncey Billups’ ‘rigged poker games’
- Flau’jae Johnson Shuts Down Governor’s Call for Charlie Kirk Statue at LSU, Social Media Rides With Her
- How Discrimination and Stress Impact the Mental Health of Young Sexual Minority Men
- Disney Ended Doctor Who Partnership for These 3 Reasons
- Shares of Navan Down 16% In Long-Awaited IPO Debut
- South Africa Needs A Collaborative And Coordinated AI Skills Strategy - iAfrica.com
- A Political Turning Point: Lessons from Sameer Suleman’s Election as Speaker of Malawi’s Parliament Malawi 24 | Latest News from Malawi
- These celebs have confessed about sex with other celebs